Novartis India Review: Potential Acquisition by Dr. Reddy’s
Novartis AG, a Swiss pharmaceutical giant, has commenced a strategic review of its subsidiary, Novartis India Limited. This evaluation encompasses various aspects, including Novartis AG’s substantial 70.68 percent shareholding in the Indian entity. Dr. Reddy’s Shows Interest in Acquiring Novartis AG’s Stake Indian pharmaceutical major Dr. Reddy’s is reportedly eyeing Novartis AG’s stake in Novartis…